2连板翔宇医疗：目前主要聚焦非侵入式脑机接口技术 截至2025年末尚未实现规模化销售

Core Viewpoint - The recent surge in market interest towards brain engineering and brain-machine interface concepts has led to significant stock price increases in related sectors [1] Company Focus - The company is primarily focused on non-invasive brain-machine interface technology, which encompasses a comprehensive rehabilitation layout including occupational therapy, motor therapy, cognitive speech, and swallowing [1] - This approach differs from the current international trend towards invasive brain-machine interface technologies [1] Market Position and Development - The company has made certain advancements in technology, products, and market channels related to brain-machine interfaces [1] - However, the company faces challenges in bidding and sales processes, which exhibit a lagging effect [1] - As of the end of 2025, the company does not expect to achieve large-scale sales of related products, resulting in a relatively small revenue contribution [1]